<p> Referencing PBM-MAP-VPE Posted Clinical Guidance Documents,</p><p>Educational Materials, and VA/DoD Clinical Practice Guidelines</p><p>1. Clinical Guidance documents developed by the Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives should be referenced using the following format: </p><p>Title of guidance. Washington, DC: Pharmacy Benefits Management Services, Medical Advisory Panel and VISN Pharmacist Executives, Veterans Health Administration, Department of Veterans Affairs; Month Year. </p><p>Example: </p><p>Dalfampridine (Ampyra®) Criteria for Use. Washington, DC: Pharmacy Benefits Management Services, Medical Advisory Panel, VISN Pharmacist Executives and MSCoE Directors, Veterans Health Administration, Department of Veterans Affairs; September 2010. </p><p>2. National VA/DoD joint guidelines developed through the Office of Quality and Performance should be referenced using the following format: </p><p>Title of guideline. Washington, DC: Office of Quality and Performance and the Veterans Affairs and Department of Defense Development Work Group, Veterans Health Administration, Department of Veterans Affairs; Month Year. Office of Quality and Performance publication XX-XXXX. </p><p>Example:</p><p>Management of Substance Use Disorder in the Primary Care Setting. Washington, DC: VA/DoD Evidence-Based Clinical Practice Guideline Working Group, Veterans Health Administration, Department of Veterans Affairs, and Health Affairs, Department of Defense, 2009. Office of Quality and Performance publication 10Q-CPG/SUD-09.</p><p>3. National VA/DoD joint Practice guidelines developed through the Office of Quality and Performance (electronic version) should be referenced using the following format: </p><p>Name of Working Group. (Year). Title of guideline. Electronic Version. Washington, DC: Veterans health Administration and Department of Defense.</p><p>Example: </p><p>Chronic Kidney Disease Working Group. (2008). VA/DoD clinical practice guideline for the management of chronic kidney disease in primary care. Version 2.0. Washington, DC: Veterans Health Administration and Department of Defense. </p><p>4. PowerPoint Slides used in Live Meeting Program</p><p>Author. (Year). Title [PowerPoint slides]. Retrieved from (web URL)</p><p>Example: Dolder, NM and Surdy MJ. (2011). Hepatitis C Therapy and New Oral HCV Protease Inhibitors. [PowerPoint slides]. Retrieved from http://vaww.national.cmop.va.gov/PBM/Education%20CE%20CME/Forms/AllItems.aspx?RootFolder=http%3a %2f%2fvaww%2enational%2ecmop%2eva%2egov%2fPBM%2fEducation%20CE%20CME%2fDistance %20Learning%20Broadcasts%20and%20Other%20Educational %20Opportunities&FolderCTID=0x012000B046A5A05C6D8C43855BC0B346B52F94</p>